Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ASPC | A Spac III Acquisition Corp. | $24.01 | $10.59 | 78.91% | 7.4M | $31M | $9.95$63.98 |
| UPC | Universe Pharmaceuticals Inc | $5.62 | $1.34 | 31.16% | 3.4M | $2.4M | $2.51$28.00 |
| KXIN | Kaixin | $6.00 | $1.26 | 26.58% | 1.2M | $29M | $2.94$75.00 |
| GSIT | Gsi Technology | $7.65 | $1.59 | 26.24% | 19.5M | $214M | $1.62$18.15 |
| AHMA | Ambitions Enterprise Management L.l.c | $7.38 | $1.47 | 24.87% | 128.7K | $174M | $4.00$18.20 |
| SQFT | Presidio Property Trust | $3.94 | $0.69 | 21.23% | 7.3M | $4.7M | $2.60$23.00 |
| IKT | Inhibikase Therapeutics | $2.00 | $0.35 | 21.21% | 2.1M | $200M | $1.33$3.49 |
| GLSI | Greenwich LifeSciences | $20.69 | $3.48 | 20.19% | 1.3M | $238M | $7.78$22.31 |
| JLHL | Julong | $4.34 | $0.65 | 17.61% | 97.2K | $78M | $2.70$6.30 |
| RKLZ | Tidal Trust II - Defiance Daily Target 2x Short Rklb ETF | $5.03 | $0.74 | 17.25% | 9.9M | - | $4.02$25.51 |
Related Articles
Featured Article
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
Advertisement